Westchester Medical Center, the flagship academic medical center for the Westchester Medical Center Health Network (WMCHealth), is set to become the first hospital in New York State to introduce the non-invasive surgical robotics platform, the ZAP-X® Gyroscopic Radiosurgery®,
In keeping with its mission to embrace innovation and leverage cutting-edge technology, Postal Center International® (PCI®) has made a strategic investment in not one but two new state-of-the-art BlueCrest Vantage Mixed Thickness and Mixed Weight Flat Sorters — the first ones in the United States running on the NetSort platform.
In a landmark collaboration, Sodexo, a global leader in quality-of-life services, is expanding its partnership with Bear Robotics, the Silicon Valley innovator behind indoor self-driving service robots. Together, they are reshaping healthcare services, ushering in a new era of patient and staff support and care that will establish an industry benchmark for excellence.
GE HealthCare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with 70 to 80 percent accuracy1, based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer (SITC) in San Diego, U.S., by GE HealthCare, Vanderbilt University Medical Center (VUMC) and the University Medicine Essen (UME), Germany.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced initial findings from the multicenter observational study Assessing Brain Injury Using Portable Magnetic Resonance Imaging in Patients With Extracorporeal Membrane Oxygenation.
ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, launches its clinical strength Tru Niagen® Pro 1,000mg, featuring 1,000mg of Niagen® (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.
Skeletal muscle fibrosis which leads to locomotor dysfunction in Duchenne Muscular Dystrophy (DMD) could be significantly reduced by oral consumption of Neu-REFIX beta 1,3-1,6 glucans alone for 45 days without any other drugs, in MDX mice model of DMD.
Shanghai Kehua Bio-engineering Co., Ltd. China's leading In Vitro Diagnostic (IVD) company has achieved a significant milestone by becoming the first Chinese company to obtain EU Class D In Vitro Diagnostic Regulation (IVDR) certification for rapid tests.
As parents stock up their medicine cabinets for cold and flu season, DrKids, the leader in innovative, effective medicines and supplements, has introduced the first ever acetaminophen gummy bite.
Home-use medical device manufacturer Hexainnoheal has been gaining recognition for its pain therapy products. Hexainnoheal manufactures healthcare devices using Low Level Lasers and LED lighting. Its primary product line-up includes PainQ for pain management and CobiQ for rhinitis management. Hexainnoheal also focuses on developing a new product called Flexible PainQ.